Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | S-588210 |
Synonyms | |
Therapy Description |
S-588210 is a cancer vaccine comprised of an injectable formulation of S-488210 and S-488211 that together contain five different HLA-A*02:01-restricted peptides, which may lead to a cytotoxic T-lymphocyte response against tumor cells and decreased tumor growth (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
S-588210 | S 588210|S588210|S-488210/S-488211 | S-588210 is a cancer vaccine comprised of an injectable formulation of S-488210 and S-488211 that together contain five different HLA-A*02:01-restricted peptides, which may lead to a cytotoxic T-lymphocyte response against tumor cells and decreased tumor growth (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|